Oberland Biotech Secures CHF 2.5 Million in Seed Funding for Global Expansion

Oberland Biotech GmbH, a biotechnology and nutritional food company based in Zug, Switzerland, has successfully closed a CHF 2.5 million seed funding round led by 999 Family Office Pte. Ltd. The company focuses on the trade, sale, and export of nutritional supplements and food products internationally.

The funding will be utilized to drive product development, international expansion, recruitment, and marketing and sales growth. Oberland Biotech plans to strengthen its presence in the United States and Asian markets while expanding its operations in the global biotechnology and nutrition sector. CEO Phillip Josef Jancer expressed gratitude to 999 Family Office Pte. Ltd for their support and guidance. Oberland Biotech GmbH is committed to developing and scaling innovative solutions in the food and biotechnology sector.

Source: PR NewsWire